metformin has been researched along with 2,4-thiazolidinedione in 83 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (3.61) | 18.2507 |
| 2000's | 40 (48.19) | 29.6817 |
| 2010's | 33 (39.76) | 24.3611 |
| 2020's | 7 (8.43) | 2.80 |
| Authors | Studies |
|---|---|
| Caro, JF; Kolaczynski, JW | 1 |
| Bloomgarden, ZT | 1 |
| Riddle, MC | 1 |
| Currier, JS | 1 |
| Taylor, AE | 1 |
| Slagle, M | 1 |
| Kuritzky, L; Quillen, DM | 1 |
| Abourjaily, HM; Alsheikh-Ali, AA; Karas, RH | 1 |
| Legro, RS | 1 |
| Halimi, S | 1 |
| Dove, A | 1 |
| Sakura, H | 1 |
| Chawla, S; Takiya, L | 1 |
| Gin, H; Rigalleau, V | 1 |
| Hoogwerf, BJ; Nambi, V; Sprecher, DL | 1 |
| Foody, JM; Havranek, EP; Inzucchi, SE; Krumholz, HM; Masoudi, FA; Setaro, JF; Wang, Y | 1 |
| Vigouroux, C | 1 |
| Satoh, J | 1 |
| Bell, DS | 1 |
| Béréziat, V; Burnol, AF; Capitaine, N; Cariou, B; Girard, J; Kergoat, M; Laville, M; Le Marcis, V; Vega, N; Vidal, H | 1 |
| Jacobson-Dickman, E; Levitsky, L | 1 |
| Berlin, JA; Cappola, AR; Kimmel, SE; Sauer, WH | 1 |
| Bodles, AM; Fried, SK; Kern, LM; Kern, PA; Lee, MJ; McGehee, RE; Phanavanh, B; Rasouli, N; Spencer, HJ; Starks, T; Varma, V; Yao-Borengasser, A | 1 |
| Brodows, RG; Durán García, S; Giaconia, JM; Hoogwerf, BJ; Kim, DD; Milton, DR; Trautmann, ME; Zinman, B | 1 |
| Malozowski, S | 1 |
| Goldberg, RA; Lee, S; McCann, JD; Tsirbas, A | 1 |
| Heien, H; Plauschinat, CA; Riedel, AA; Wogen, J | 1 |
| Benjasuratwong, Y; Bunnag, P; Chetthakul, T; Deerochanawong, C; Komoltri, C; Kosachunhanun, N; Krittiyawong, S; Leelawatana, R; Mongkolsomlit, S; Ngarmukos, C; Plengvidhya, N; Pratipanawatr, T; Rawdaree, P; Suwanwalaikorn, S | 1 |
| Bolli, G; Cohen, SE; Dotta, F; Rochotte, E | 1 |
| Hunt, JS; Plauschinat, C; Rozenfeld, Y; Wong, KS | 1 |
| Nogid, A; Pham, DQ; Plakogiannis, R | 1 |
| Alemao, E; Alexander, CM; Alvarez Guisasola, F; Mavros, P; Nocea, G; Yin, D | 1 |
| Alvarez Guisasola, F; Krishnarajah, G; Lyu, R; Mavros, P; Tofé Povedano, S; Yin, D | 1 |
| Chang, YH; Hsiao, PJ; Li, TH; Lin, KD; Shin, SJ; Wang, CL; Yang, YH | 1 |
| Hunter, A; Liu, W; Ma, J; Zhang, W | 1 |
| Balkrishnan, R; Engel, S; Erdesz, D; Jermendy, G; Karve, S; Nagy, L; Phatak, H; Yin, D | 1 |
| Barnett, AH | 1 |
| August, P; Brooks, MM; Chaitman, BR; Frye, RL; Genuth, SM; Goldberg, SH; Hardison, RM; Hlatky, MA; Jones, TL; Kelsey, SF; MacGregor, JM; Molitch, ME; Nesto, RW; Orchard, TJ; Sako, EY; Sobel, BE | 1 |
| Doble, M; Prabhakar, PK | 1 |
| Arakaki, RF; Belin, RM; Cuddihy, R; Heilmann, CR; Lyons, JN; Mathieu, C; Planquois, JM | 1 |
| Brown, A; Desai, M; Taneja, D; Tannock, LR | 1 |
| Ertl, G; Nitschmann, S; Störk, S | 1 |
| Barbieri, M; Boccardi, V; Canonico, S; Lettieri, B; Marfella, R; Paolisso, G; Rizzo, MR; Vestini, F | 1 |
| Banerji, MA; Francis, BH; Purkayastha, D | 1 |
| Allen, E; Chen, R; Donovan, M; Fleming, D; Karyekar, C; Ravichandran, S | 1 |
| Brooks, MM; Frye, RL; Genuth, S; Hardison, RM; Huber, K; Krishnaswami, A; McBane, RD; Pratley, RE; Schneider, DJ; Sobel, BE; Wolk, R | 1 |
| Parchman, ML; Wang, CP | 1 |
| Botha, J; Howard, CP; Rissanen, A; Thuren, T | 1 |
| Astor, BC; Ballantyne, CM; Brancati, FL; Coresh, J; Crawford, SO; Hoogeveen, RC; Matsushita, K; Mongraw-Chaffin, ML; Schmidt, MI; Young, JH | 1 |
| Heo, ST; Kang, SH; Kim, J; Kim, SH; Kim, YR; Koh, G; Kwon, EJ; Lee, DH; Lee, SA; Oh, BC; Park, DB; Yang, EJ | 1 |
| Allen, E; Fleming, D; Frederich, R; Karyekar, CS; Ravichandran, S | 1 |
| Allen, E; Bryzinski, B; Cook, W; Frederich, R; Slater, J | 1 |
| Capuano, A; Ciardiello, F; Della Corte, CM; Festino, L; Manzo, A; Martinelli, E; Morgillo, F; Sasso, FC; Troiani, T | 1 |
| Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J | 1 |
| Borders-Hemphill, V; Hampp, C; Moeny, DG; Wysowski, DK | 1 |
| Dai, X; Fu, P; Jing, Z; Wang, H | 1 |
| Chan, JC; Cheung, KK; Chow, CC; Kong, AP; Lee, HM; Luk, A; Ma, RC; Ozaki, R; So, WY; Xu, G; Yang, X; Yu, L | 1 |
| Avorn, J; Berkowitz, SA; Brennan, T; Brill, G; Choudhry, NK; Krumme, AA; Matlin, OS; Pezalla, EJ; Shrank, WH; Spettell, CM | 1 |
| Araki, E; Broedl, UC; Kim, G; Koiwai, K; Salsali, A; Tanaka, Y; Taniguchi, A; Tanizawa, Y; Woerle, HJ | 1 |
| Dotta, F; Festa, A; Gallwitz, B; Guerci, B; Kiljański, J; Rosas-Guzmán, J; Schernthaner, G; Simó, R; Zhou, M | 1 |
| Kannan, S; Karafa, M; Matsuda, S; Pantalone, KM; Wells, BJ; Zimmerman, RS | 1 |
| Barnhart, C; Lee, SJ; McClymont, K; Steinman, MA; Stijacic-Cenzer, I | 1 |
| Donnelly, L; Farmer, AJ; Hattersley, AT; Holman, RR; Lonergan, M; Pearson, ER; Rodgers, LR; Shields, B; Weedon, MN | 1 |
| Greevy, RA; Griffin, MR; Grijalva, CG; Hung, AM; Liu, X; Roumie, CL | 1 |
| Bisson, GP; Gibert, CL; Gordon, K; Han, JH; Leaf, DA; Rimland, D; Rodriguez-Barradas, MC; Womack, JA | 1 |
| Flory, J; Gerhard, T; Keating, S; Rowan, CG; Stempniewicz, N | 1 |
| Choi, H; Ha, KH; Kim, B; Kim, DJ; Kim, HC | 1 |
| Kosiborod, M; Leiter, LA; Poulter, NR; Rajagopalan, S; Ray, K; Vora, J | 1 |
| Bezemer, ID; Hall, GC; Hammar, N; Heintjes, EM; Lapi, F; Overbeek, JA; Prieto-Alhambra, D | 1 |
| IJzerman, RG; Muskiet, MHA; van Baar, MJB; van Bloemendaal, L; van Raalte, DH; van Ruiten, CC | 1 |
| Christiansen, CL; Miller, DR; Powell, WR | 1 |
| Ha, KH; Kim, DJ; Kim, HC; Lee, H; Lee, JH; Lee, SJ | 1 |
| Dennis, JM; Hattersley, AT; Henley, WE; Jones, AG; Shields, BM | 1 |
| Cao, Y; E, M; Li, F; Liu, Y; Tang, J; Tao, Y; Zhang, Z | 1 |
| Anwar, MM; Awad, M; Carapinha, JL; Elebrashy, I; Elhadad, H; Elsisi, GH; Khattab, M; Wafa, A | 1 |
| Han, M; Simó, R; Tang, X; Yang, J; Zhou, JB | 1 |
| Brinton, RD; Chen, Z; Farland, LV; Klimentidis, Y; Migrino, R; Reaven, P; Rodgers, K; Tang, X; Zhou, JJ | 1 |
| Chan, JCN; Chow, E; Fan, B; Kong, APS; Lau, ESH; Luk, AOY; Ma, RCW; So, WY; Wu, H; Yang, A | 1 |
| Abutheraa, N; Kurdi, A; Mahmoud, F; Mueller, T; Mullen, A; Rushworth, GF; Sainsbury, C; Yasin, H | 1 |
| Levita, J; Sumiwi, SA; Susilawati, E; Susilawati, Y | 1 |
25 review(s) available for metformin and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Insulin resistance: site of the primary defect or how the current and the emerging therapies work.
Topics: Adipose Tissue; Appetite Depressants; Diabetes Mellitus, Type 2; Female; Fenfluramine; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Ligands; Metformin; Thiazoles; Thiazolidinediones | 1998 |
Oral pharmacologic management of type 2 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; United States | 1999 |
Insulin-lowering medications in polycystic ovary syndrome.
Topics: Diazoxide; Female; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Menstruation Disturbances; Metformin; Polycystic Ovary Syndrome; Thiazoles; Thiazolidinediones | 2000 |
Diabetes mellitus. Medication update.
Topics: alpha-Glucosidases; Benzamides; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Type 2 diabetes management: a comprehensive clinical review of oral medications.
Topics: Benzamides; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Polycystic ovary syndrome. Long term sequelae and management.
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Contraceptives, Oral; Diabetes Mellitus, Type 2; Diagnosis, Differential; Endometrial Neoplasms; Female; Humans; Hyperlipidemias; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Pregnancy; Progestins; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles; Thiazolidinediones | 2002 |
[Is a new therapeutic class justified in the treatment of type 2 diabetes?].
Topics: Administration, Oral; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Thiazoles; Thiazolidinediones | 2002 |
[Combination therapy with biguanides].
Topics: Acarbose; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone | 2002 |
Therapeutic options for the management of type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 2; Disease Management; Education, Medical, Continuing; Education, Pharmacy, Continuing; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Aspart; Managed Care Programs; Metformin; Thiazoles; Thiazolidinediones; United States | 2002 |
Oral anti diabetic polychemotherapy in type 2 diabetes mellitus.
Topics: Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Thiazoles; Thiazolidinediones | 2002 |
A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Metabolic Syndrome; Metformin; Motor Activity; Obesity; Simvastatin; Thiazoles; Thiazolidinediones; Weight Loss | 2002 |
[Lipodystrophies: what treatment?].
Topics: Antiviral Agents; Diabetes Complications; Diabetes Mellitus; Diet; Exercise; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin Resistance; Metformin; Thiazoles; Thiazolidinediones | 2003 |
[Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
Topics: Adipocytes; Adiponectin; Cyclic AMP-Dependent Protein Kinases; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glycerol Kinase; Humans; Hypertension; Hypoglycemic Agents; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metformin; Obesity; Proteins; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
Type 2 diabetes mellitus: what is the optimal treatment regimen?
Topics: Administration, Oral; Algorithms; B-Lymphocytes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Metformin; Thiazolidinediones | 2004 |
Sitagliptin: a novel agent for the management of type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Thiazolidinediones; Triazoles | 2008 |
Translating science into clinical practice: focus on vildagliptin in combination with metformin.
Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Nitriles; Pyrrolidines; Sulfonylurea Compounds; Thiazolidinediones; Vildagliptin | 2009 |
Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
Topics: Amyloid; Bariatric Surgery; Diabetes Mellitus; Diet, Reducing; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Exercise; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Liraglutide; Metformin; Obesity; Peptides; Thiazolidinediones; Treatment Failure; Venoms; Weight Loss | 2010 |
Metformin in lung cancer: rationale for a combination therapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Diabetes Mellitus; Humans; Hypoglycemic Agents; Lung Neoplasms; Metformin; Thiazolidinediones | 2013 |
The effect of a dual combination of noninsulin antidiabetic drugs on lipids: a systematic review and network meta-analysis.
Topics: Biomarkers; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Metformin; Models, Statistical; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triglycerides | 2014 |
Cancer risks of anti-hyperglycemic drugs for type 2 diabetes treatment - a clinical appraisal.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Incretins; Insulin; Metformin; Neoplasms; Risk Factors; Thiazolidinediones | 2017 |
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Metformin; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2018 |
Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis.
Topics: Diabetes Mellitus, Type 2; Fractures, Bone; Humans; Hypoglycemic Agents; Insulin; Metformin; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones | 2020 |
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
Topics: Bayes Theorem; Dementia; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Metformin; Network Meta-Analysis; Protective Agents; Risk; Sulfonylurea Compounds; Thiazolidinediones | 2020 |
Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Sodium-Glucose Transporter 2; Sulfonylurea Compounds; Thiazolidinediones | 2023 |
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin, Regular, Human; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2023 |
12 trial(s) available for metformin and 2,4-thiazolidinedione
| Article | Year |
|---|---|
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Nausea; Peptides; Thiazolidinediones; Venoms; Vomiting; Weight Loss | 2007 |
Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitriles; Pioglitazone; Pyrrolidines; Thiazolidinediones; Treatment Outcome; Vildagliptin | 2008 |
Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea.
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Retinol-Binding Proteins, Plasma; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Infarction; Stroke; Sulfonylurea Compounds; Thiazolidinediones | 2009 |
A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial.
Topics: Administration, Inhalation; Adult; Aged; Body Mass Index; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Thiazolidinediones; Vital Capacity | 2009 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Thiazolidinediones; United States; Young Adult | 2011 |
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Topics: Adult; Biomarkers; C-Reactive Protein; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Revascularization; Plasminogen Activator Inhibitor 1; Prognosis; Sulfonylurea Compounds; Thiazolidinediones; Thrombophilia; Tissue Plasminogen Activator | 2011 |
Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Interleukin-1beta; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2012 |
Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus.
Topics: Adamantane; Aged; Aged, 80 and over; Analysis of Variance; Area Under Curve; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Male; Metformin; Thiazolidinediones; Treatment Outcome | 2013 |
Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials.
Topics: Adamantane; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemic Agents; Metformin; Risk Factors; Thiazolidinediones | 2013 |
Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Benzhydryl Compounds; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2015 |
Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Europe; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Peptides; Prospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Failure; Venoms | 2015 |
46 other study(ies) available for metformin and 2,4-thiazolidinedione
| Article | Year |
|---|---|
American Diabetes Association Annual Meeting, 1998. Treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Nuclear Proteins; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
Topics: Anabolic Agents; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Exercise Therapy; Gemfibrozil; Growth Hormone; Guidelines as Topic; Heptanoic Acids; HIV Infections; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Lipodystrophy; Metabolic Diseases; Metformin; Nucleosides; Protease Inhibitors; Pyrroles; Reverse Transcriptase Inhibitors; Risk Factors; Thiazoles; Thiazolidinediones | 2000 |
[Type 2 diabetes. Regulating insulin according to need].
Topics: Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Metformin; Nateglinide; Phenylalanine; Thiazoles; Thiazolidinediones | 2001 |
Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose).
Topics: Acarbose; Adverse Drug Reaction Reporting Systems; Anticholesteremic Agents; Atorvastatin; Chromans; Drug Interactions; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrroles; Simvastatin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Seeking sweet relief for diabetes.
Topics: Behavior Control; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet; Exercise; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; United States | 2002 |
Metformin and thiazolidinedione use in Medicare patients with heart failure.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Contraindications; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Drug Utilization Review; Female; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Male; Medicare; Metformin; Retrospective Studies; Thiazoles; Thiazolidinediones; United States | 2003 |
Diabetes drugs a problem in heart failure.
Topics: Diabetes Complications; Diabetes Mellitus; Heart Failure; Humans; Hypoglycemic Agents; Metformin; Thiazolidinediones | 2003 |
Increased adipose tissue expression of Grb14 in several models of insulin resistance.
Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Adipocytes; Adipose Tissue; Animals; Carrier Proteins; Diabetes Mellitus, Type 2; Disease Models, Animal; Fasting; Gene Expression Regulation; Insulin; Insulin Resistance; Liver; Metformin; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscles; Obesity; Proteins; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2004 |
Oral agents in managing diabetes mellitus in children and adolescents.
Topics: Administration, Oral; Adolescent; Carbamates; Child; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2005 |
Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus.
Topics: Adult; Aged; Case-Control Studies; Confounding Factors, Epidemiologic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Philadelphia; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2006 |
Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
Topics: Abdominal Fat; Biomarkers; Biopsy; Body Mass Index; Cytokines; Gene Expression; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Insulin Resistance; Lipid Metabolism; Metformin; Muscle, Skeletal; Nicotinamide Phosphoribosyltransferase; Obesity; Pioglitazone; RNA, Messenger; Thiazolidinediones | 2007 |
Summaries for patients. Exenatide therapy for type 2 diabetes.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Male; Metformin; Middle Aged; Nausea; Peptides; Thiazolidinediones; Venoms; Vomiting; Weight Loss | 2007 |
Exenatide in combination therapy: small study, big market, and many unanswered questions.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Humans; Hypoglycemic Agents; Metformin; Peptides; Research Design; Thiazolidinediones; Venoms | 2007 |
Thiazolidinedione induced thyroid associated orbitopathy.
Topics: Diplopia; Disease Progression; Drug Therapy, Combination; Exophthalmos; Female; Graves Ophthalmopathy; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Metformin; Middle Aged; Propranolol; Propylthiouracil; Retreatment; Rosiglitazone; Thiazolidinediones | 2007 |
Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.
Topics: Aged; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Disease Management; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insurance Claim Review; Male; Managed Care Programs; Metformin; Middle Aged; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Failure; United States | 2007 |
Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Program Development; Program Evaluation; Registries; Sulfonylurea Compounds; Thailand; Thiazolidinediones; Treatment Outcome | 2006 |
Oral antidiabetic medication adherence and glycemic control in managed care.
Topics: Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insurance Claim Review; Male; Metformin; Middle Aged; Oregon; Patient Compliance; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
Topics: Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Europe; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Treatment Outcome | 2008 |
Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.
Topics: Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Europe; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Patient Compliance; Patient Satisfaction; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
Performing meta-analysis with incomplete statistical information in clinical trials.
Topics: Antihypertensive Agents; Cholesterol, LDL; Clinical Trials as Topic; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Intraocular Pressure; Latanoprost; Meta-Analysis as Topic; Metformin; Ocular Hypertension; Prostaglandins F, Synthetic; Sampling Studies; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Timolol | 2008 |
Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hungary; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Patient Satisfaction; Quality of Life; Sickness Impact Profile; Sulfonylurea Compounds; Thiazolidinediones; Treatment Failure; Treatment Outcome | 2008 |
Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes.
Topics: Animals; Berberine; Biological Transport; Cells, Cultured; Chlorogenic Acid; Coumaric Acids; Deoxyglucose; Drug Synergism; Drug Therapy, Combination; Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; Metformin; Muscle Fibers, Skeletal; Muscle, Skeletal; Phenols; Phosphatidylinositol 3-Kinases; Plant Extracts; PPAR gamma; Rats; Thiazolidinediones | 2009 |
[Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Myocardial Infarction; Stroke; Sulfonylurea Compounds; Thiazolidinediones | 2010 |
Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Thiazolidinediones | 2010 |
Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study.
Topics: Adamantane; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Drug Tolerance; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Kidney Function Tests; Male; Metformin; Middle Aged; Nitriles; Pyrrolidines; Retrospective Studies; Safety; Thiazolidinediones; Vildagliptin | 2010 |
Initiation of insulin among veterans with type 2 diabetes and sustained elevation of A1c.
Topics: Acarbose; Aged; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 2; Electronic Health Records; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Proportional Hazards Models; Sulfonylurea Compounds; Thiazolidinediones; Veterans | 2012 |
Diabetes medication use and blood lactate level among participants with type 2 diabetes: the atherosclerosis risk in communities carotid MRI study.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Blood Glucose; Cohort Studies; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lactic Acid; Male; Metformin; Middle Aged; Risk Factors; Thiazolidinediones | 2012 |
CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Female; Humans; Male; Metformin; Middle Aged; T-Lymphocytes; Thiazolidinediones | 2013 |
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Kidney Failure, Chronic; Metformin; Microcirculation; Middle Aged; Myocardial Infarction; Nutrition Surveys; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Uric Acid | 2014 |
Use of antidiabetic drugs in the U.S., 2003-2012.
Topics: Adult; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Prescriptions; Drug Therapy, Combination; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Marketing of Health Services; Metformin; Pharmacies; Prescription Drugs; Pyrazines; Rosiglitazone; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles; United States | 2014 |
Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose; Hemoglobin A; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Male; Metformin; Neoplasms; Renin-Angiotensin System; Risk; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones | 2014 |
Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Topics: Administration, Oral; Adult; Aged; Cohort Studies; Comparative Effectiveness Research; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Drug Prescriptions; Female; Guideline Adherence; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Odds Ratio; Patient-Centered Care; Practice Guidelines as Topic; Propensity Score; Proportional Hazards Models; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones | 2014 |
Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Heart Failure; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Peptide Fragments; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Survival Rate; Thiazolidinediones | 2016 |
Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011.
Topics: Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Drug Utilization; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Nursing Homes; Practice Patterns, Physicians'; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones; United States; United States Department of Veterans Affairs | 2015 |
Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
Topics: Aged; Blood Glucose; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Middle Aged; Primary Health Care; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones | 2016 |
Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
Topics: Body Mass Index; Cohort Studies; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Practice Guidelines as Topic; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2016 |
Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans.
Topics: Adult; Black or African American; Blood Glucose; Body Mass Index; Comparative Effectiveness Research; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycated Hemoglobin; Hispanic or Latino; HIV Infections; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones; Veterans; White People | 2017 |
Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
Topics: Aged; Cohort Studies; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Electronic Prescribing; Female; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin; Insurance, Pharmaceutical Services; Longitudinal Studies; Male; Medicare Part C; Medicare Part D; Medication Adherence; Metformin; Middle Aged; Practice Patterns, Physicians'; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones; United States | 2017 |
Cardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data.
Topics: Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Republic of Korea; Risk Factors; Sulfonylurea Compounds; Survival Analysis; Thiazolidinediones; Time Factors; Treatment Outcome | 2017 |
Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.
Topics: Adolescent; Adult; Aged; Body Mass Index; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Europe; Female; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones; Young Adult | 2017 |
Long-term comparative safety analysis of the risks associated with adding or switching to a sulfonylurea as second-line Type 2 diabetes mellitus treatment in a US veteran population.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Observational Studies as Topic; Propensity Score; Proportional Hazards Models; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Veterans | 2019 |
Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Republic of Korea; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2019 |
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data.
Topics: Clinical Trials as Topic; Cluster Analysis; Diabetes Mellitus, Type 2; Disease Progression; Humans; Hypoglycemic Agents; Metformin; Models, Statistical; Sulfonylurea Compounds; Thiazolidinediones | 2019 |
Budget impact analysis for dapagliflozin in type 2 diabetes in Egypt.
Topics: Benzhydryl Compounds; Budgets; Cardiovascular Diseases; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Egypt; Glucosides; Humans; Hypoglycemic Agents; Insulin; Metformin; Models, Economic; Renal Insufficiency; Sulfonylurea Compounds; Thiazolidinediones; Time Factors | 2020 |
Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Veterans | 2022 |
Real world evidence of clinical predictors of glycaemic response to glucose-lowering drugs among Chinese with type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; East Asian People; Glucose; Humans; Hypoglycemic Agents; Male; Metformin; Sulfonylurea Compounds | 2023 |